Special Issue "The Latest Development of Multifunctional Nanopharmaceutical Formulations and Its Application"
Deadline for manuscript submissions: 30 September 2023 | Viewed by 4430
Interests: fabrication of multifunctional pharmaceutical formulations and overcoming barriers in oral/transdermal drug delivery
Interests: development of targeted drug delivery systems for neurodegenerative diseases and cancer therapy
Special Issues, Collections and Topics in MDPI journals
Due to their high surface area, high saturation solubility and adjustable surface, nanopharmaceuticals, including liposome, polymeric micelles, dendrimers, quantum dots, nanocrystals, etc., have attracted the attention of many researchers in the pharmaceutical fields. Multifunctional agents modified on the surface of various nanoparticles have stimulated the development of pharmaceutical applications, such as passive or active ligands, with both their imaging and therapeutic capabilities, thus allowing simultaneous monitoring and treatment. The rational design and evaluation of multifunctional nanopharmaceuticals with improved drug efficiency, transportation of the drug across physiological barriers and reduced drug-related toxicity will accelerate the development of drugs from lab to clinical applications.
The aim of this Special Issue is to deliver an up-to-date overview on multifunctional nanopharmaceutical formulations fabricated with novel multifunctional agents and technologies, and to explore their applications in the treatment of various diseases via oral, dermal, transdermal and nasal delivery routines, establishing increased effectiveness and safety in drug therapy, among other applications.
Dr. Xiaoqing Miao
Dr. Tongkai Chen
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- multifunctional modification
- drug delivery
- physiological barriers
- improved bioavailability
- biomedical applications